Full List Of Stories
Director dealings: Aveva director snaps up shares
Aveva Group revealed on Monday that non-executive director Peter Herweck had acquired 2,500 ordinary shares in the FTSE 100-listed engineering and industrial software company.
Broker tips: Cineworld, Dixons Carphone, Shearwater, BT, TalkTalk and Vodafone
JPMorgan Cazenove downgraded shares of Cineworld to ‘neutral’ from ‘overweight’ on Monday and slashed the price target to 90p from 300p after the company shut the doors to its cinemas due to the coronavirus outbreak.
Numis sees improved H2 revenues despite 'unprecedented times'
Investment banking group Numis Corporation expects to report a 10% jump in second-half revenues despite the period being marred with elevated political uncertainty and significant declines in global markets in reaction to the Covid-19 pandemic.
US open: Indices surge as Johnson & Johnson identifies lead candidate for coronavirus treatment
Wall Street trading began on a positive note on Monday as Johnson & Johnson identifies a lead candidate for coronavirus treatment.
Berenberg lowers target price on Shearwater despite 'reassuring trading update'
Analysts at Berenberg lowered their target price on software provider Shearwater Group from 500. 0p to 400. 0p on Monday despite the firm's "reassuring trading update" from last week.
US pre-open: Futures point to mixed trading as global Covid-19 cases top 713,000
Wall Street futures were pointing to a mixed open on Monday as confirmed cases of Covid-19 in the US continued to rise over the weekend.
Franchise Brands suggests shareholders accept scrip dividend
Franchise Brands urged investors on Monday to accept dividend payments in shares rather than cash in order to help maintain the group's financial strength amid the Covid-19 outbreak.
Ten Lifestyle warns on revenues, announces voluntary salary sacrifice
Travel service platform provider Ten Lifestyle Group warned on revenues on Monday as it said the Covid-19 pandemic had "significantly impacted" trading, and announced a voluntary salary sacrifice.
Morses Club withdraws guidance after Covid-19 outbreak
Doorstep lender Morses Club said on Monday that it was withdrawing its full-year guidance as it continues to assess the impact of the coronavirus outbreak on its business.
AstraZeneca gets FDA approval, stops kidney drug trial after 'overwhelming efficacy'
Biopharmaceutical giant AstraZeneca said on Monday that two of its top-selling drugs had shown advances in the treatment of deadly diseases.
Synthomer chair to stand down at end of 2020
Chemicals company Synthomer said on Monday that long-time chairman Neil Johnson will be standing down from the role at the end of the year.